Focus
Malpractice lawyers, HPCSA, hospital CEOs and private healthcare – all under fire
Health Minister Dr Aaron Motsoaledi has in short order sharply criticised medical malpractice lawyers, instituted an inquiry into the Health Professions Councils of SA (HPCSA), another into state hospital CEOs, and been highly critical of specialists and private hospital groups: * State hospital CEOs are in cahoots with malpractice lawyers, says Motsoaledi, ‘deliberately failing to apply norms and standards’, hoping something would go wrong. They then colluded with state attorneys to deliberately ‘mismanage ... so that we lose the case’. The SA Medical Association notes ‘several cases where nurses and admin clerks are being investigated for selling patient files to lawyers specialising in malpractice’. * Motsoaledi has appointed a six-person panel to investigate claims of poor governance and mismanagement at the HPCSA. * Motsoaledi has blamed ‘profit-maximising specialists and hospitals’ for the high cost of medical care in the DOH submission to the Competition Commission inquiry into private healtcare.
Summary report drawn from City Press, Polity, HPCSA, Politicsweb, Moneyweb and DOH material
Campaign against 'too much medicine'
Global food giants revisit use of antibiotics
‘National crisis’ in obs/gynae, neurosurgery, neonatology and orthopaedics
Summary drawn from Business Day, Citizen, IOL and Health ministry materials
Dr Aaron Motsoaledi has accused personal injury lawyers of creating a ‘national crisis’ similar to that which collapsed of the Australian health system 15 years ago, with doctors scared of certain specialist areas. The government faces contingent liabilities of R25bn for medical malpractice lawsuits, while private sector doctors are battling to keep up with steeply rising premiums for professional indemnity cover.
Some medical specialities are ‘continually, persistently, and mercilessly being targeted for litigation’, said Motsoaledi, noting that he would like to see some public hospitals CEOs arrested for being part of syndicates that were looting funds.Expert committee redefines and renames ME/CFS
'Flawed research' accusations
New guidelines from CDC and NHS on patient deaths
Studies shoot down 'inflated' statin claims
Health dangers of smoking far worse than thought
Sugar-coating the research pill
Top herbal products 'fraudulent and potentially dangerous'
CPR guidelines mistaken on depth of compressions
'Significant' increase in dementia risk
New insights into an old problem
Proclamation led to 'untenable and unintended’ situation
From soil micro-organism to pharmaceutical gold
A new antibiotic – the first in nearly 30 years – has been discovered by scientists who claim it appears to be as good, or better, than many existing drugs ,with the potential to work against a broad range of fatal infections such as pneumonia and tuberculosis. Successful in animal tests, the antibiotc is born from a new way to tap the powers of soil microorganisms,
Because resistance can evolve quickly, the high costs of drug development aren't seen as having long-term value, and fewer new antibiotics are reaching the market. However, he prototype drug, called teixobactin, works against harmful bacteria in a unique way that is highly unlikely to lead to drug-resistance.
Report drawn from The Independent, Smithsonian Mag, Nature, Business Day and The Guardian
